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In this multicenter, prospective study of 288 children
(half under 2 years of age) undergoing cardiac surgery,
we evaluated whether the measurement of pre- and
postoperative serum cystatin C (CysC) improves the prediction
of acute kidney injury (AKI) over that obtained by serum
creatinine (SCr). Higher preoperative SCr-based estimated
glomerular filtration rates predicted higher risk of the
postoperative primary outcomes of stage 1 and 2 AKI (adjusted
odds ratios (ORs) 1.5 and 1.9, respectively). Preoperative CysC
was not associated with AKI. The highest quintile of
postoperative (within 6h) CysC predicted stage 1 and 2 AKI
(adjusted ORs of 6 and 17.2, respectively). The highest tertile of
percent change in CysC independently predicted AKI, whereas
the highest tertile of SCr predicted stage 1 but not stage 2 AKI.
Postoperative CysC levels independently predicted longer
duration of ventilation and intensive care unit length of stay,
whereas the postoperative SCr change only predicted longer
intensive care unit stay. Thus, postoperative serum CysC is
useful to risk-stratify patients for AKI treatment trials. More
research, however, is needed to understand the relation
between preoperative renal function and the risk of AKI.
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The development of acute kidney injury (AKI) is a risk factor
for negative hospital outcomes in adults and children who
undergo cardiac surgery.1–3 Intense contemporary research has
been directed toward validating novel biomarkers to predict
AKI earlier than is feasible with acute changes in serum
creatinine (SCr).4–7 This is with the ultimate goal being to
initiate potential AKI treatments in clinical trials and in clinical
practice eventually.8 Currently, early AKI diagnosis may direct
clinicians to apply timely conservative treatments such as
avoidance of nephrotoxins and optimization of fluid status.
Early AKI diagnosis is an especially challenging task in
children. In a previous single-centre retrospective study, we
found that a substantial proportion of children display signs of
AKI defined by acute SCr rise within hours after cardiac surgery
and that most AKI occurs within the first 2–3 postoperative
days.3 Therefore, preoperative and early postoperative clinical
data and biological markers will offer the highest chance of
capturing patients who will develop AKI or who are in the early
stages of AKI. Some studies suggest that the presence of chronic
kidney disease (CKD) is a risk factor for developing AKI in
different settings,1,9,10 although this remains inconclusive in
adults11,12 and has not been well studied in children.
Serum cystatin C (CysC) is a more accurate marker of
glomerular filtration rate (GFR) than SCr in children with
CKD.13,14 The benefit of using serum CysC for early AKI
diagnosis in critically ill patients has been controversial.15
Because CysC is a marker of filtration, it is unclear whether it
should be expressed as a percentage change from baseline
levels, when measured postoperatively for AKI prediction
(like SCr is), or whether raw concentration values should be
used. In terms of preoperative AKI risk prediction in
children, SCr concentrations are highly affected by multiple
non-renal factors, including gender, age, growth, and muscle
mass.14 Therefore CysC may offer a novel method for AKI
risk stratification before cardiac surgery.
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In this multicenter, prospective study of children
undergoing cardiac surgery, we sought to compare the
abilities of (1) preoperative SCr and CysC, and of (2) first
postoperative serum CysC and SCr to predict cardiac
surgery-associated AKI as well as secondary outcomes
including length of stay and duration of mechanical
ventilation. Because of lack of previous literature on CysC,
we also evaluated different methods of expressing post-
operative CysC for evaluating the ability of CysC to predict
AKI.
RESULTS
Study population
Among 311 children in this study, 288 were available for
analysis, after excluding subjects with missing biomarker
data. Table 1 displays the baseline and outcome character-
istics of the study cohort. Half the cohort was less than 2
years old and most subjects had normal preoperative
estimated GFR (eGFR), with 27 subjects (9%) having
preoperative eGFR below the 10th percentile of normative
age-adjusted values (Figure 1). In all, 42% of the (n¼ 288)
cohort developed stage 1 AKI or worse (X50% or 26.5mmol/l
SCr rise above baseline or need for dialysis) and 11% developed
stage 2 AKI or worse (doubling of SCr or need
for dialysis). All children who had a 26.5mmol/l rise in SCr
also had a X50% SCr rise and all patients who had a X50%
SCr rise also had a 26.5mmol/l rise in SCr from baseline.
Four of the five subjects requiring dialysis had aX50% SCr rise
from baseline at the time of dialysis initiation.
Predicting AKI from preoperative renal function with serum
creatinine and serum cystatin C
Table 2 displays the characteristics of different preoperative
renal function measures for predicting postoperative stage 1
Table 1 | Characteristics and outcomes of the study cohort
(n¼ 288)
Categorical variables: n (%)
Continuous variables: mean±s.d.,
median [interquartile range]
Male gender 159 (55%)
Age (years) 3.8±4.5, 2.1 [5.0]
p2 Years old 144 (50%)
Height/length (cm) 90±33, 81 [46.5]
Percentile 32±32, 20 [58]
Standard deviation score 0.9±2.2, 0.8 [2.2]
Weight (kg) 16.4±17.3, 10.5 [12.6]
Percentile 29±33, 12 [54]
Standard deviation score 1.1±2.0, 1.2 [2.4]
Study site
Cincinnati, Ohio 197 (68%)
Montreal, Quebec 57 (20%)
New Haven, Connecticut 34 (12%)
Operative characteristics
RACHS-1 score X3a 129 (45%)
Cardiopulmonary bypass timeb
o60min 54 (19%)
61–90min 80 (28%)
91–120min 60 (21%)
121–180min 65 (23%)
4180min 29 (10%)
Renal function
Preoperative CysC (mg/dl) 0.8±0.2, 0.73 [0.29]
Preoperative estimated GFR
(ml/min per 1.73m2)c
90.5±25.4, 87.8 [31.6]
Preoperative estimated GFR
percentilec
52.7±34, 56 [66]
First postoperative markers
Hours after surgery of 1st
postoperative blood sampling
0.6±1.3, 0.5 [0.33]
Cys C (mg/l) 0.77±0.32, 0.69 [0.38]
% SCr change from baseline 15±20, 16 [33]
% CysC change from baseline 1±27, 7 [29]
AKI and other outcomes
Stage 1 AKId 121 (42%)
Stage 2 AKId 47 (11%)
Dialysis 5 (2%)
Length of intensive care unit
stay (days)
4.0±6.1, 2.0 [3.0]
Length of hospital stay (days) 8.0±9.2, 5.0 [4.0]
Duration of mechanical
ventilation (days)
1.4±1.5, 1.0 [2.0]
Mortality 4 (1.4%)
Abbreviations: AKI, acute kidney injury; CysC, cystatin C; GFR, glomerular filtration
rate; SCr, serum creatinine.
aRisk Adjustment in Congenital Heart Surgery (RACHS)-1 score.
bFour subjects who did not receive cardiopulmonary bypass were not included in
these descriptive analyses.
cEstimated GFR (glomerular filtration) was calculated by the Schwartz formula.18
For percentile estimated GFR, normative values from children with normal renal
function was used for percentile derivation.22
dStage 1 AKI:X50% or 26.5 mmol/l SCr rise from baseline or need for dialysis; stage 2
AKI: Xdoubling of SCr from baseline or need for dialysis.
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Figure 1 |Plotted glomerular filtration rate (GFR) percentile
values for subjects less than 2 years old. Displays the percentile
curves for GFR derived from normal children from infancy to
young adulthood. Individual preoperative estimated GFR (eGFR)
of subjects from this study are plotted on the curves (þ ). To the
right of the graph, the value for each percentile (Pct) curve is
shown.
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and 2 AKI in all subjects (expressed as odds ratios (OR)
and area under the receiver operating characteristic curves
(AUC)). In the whole cohort, stage 1 AKI or worse occurred
on average 36±14 h and stage 2 AKI or worse occurred
41±12 h after the end of surgery. In unadjusted analyses,
higher preoperative CysC predicted postoperative stage 1 and
2 AKI, but this association disappeared in adjusted analyses.
There was no significant increase in AUC when CysC was
added to the regression model to predict stage 1
or 2 AKI, compared with clinical variables alone (lower
portion of Table 2). Pre-operative eGFR in ml/min per
1.73 m2 and in percentile value was significantly associated
with development of postoperative stage 1 and 2 AKI in
adjusted analyses (Table 2). There was a modest and
statistically significant increase in AUC when preoperative
eGFR was added to the predictive model, compared with
using clinical variables alone (B5% AUC increase, Po0.05),
Of note, the association between eGFR and AKI develop-
ment was positive, indicating that higher preoperative
eGFR was associated with an increased risk of AKI
development.
Comparison of first postoperative biomarkers (serum
creatinine and cystatin C) to predict AKI
Table 3 displays the ability of first postoperative CysC and
SCr to predict stage 1 or 2 AKI in patients who did not
already have these events (n¼ 241 and n¼ 267, respectively)
within the 6 h after the end of surgery. In these subjects, stage
1 AKI occurred on average 43±12 h and stage 2 AKI
occurred 48±7 h after surgery. First postoperative CysC
concentration in the 5th quintile (1.01–2.91 mg/l) was
independently associated with development of stage 1 AKI
and of stage 2 AKI (shown in the upper portion of Table 3).
First postoperative CysC X1.16 mg/l (the cutoff derived from
a previously performed study),16 was also associated with
future stage 1 AKI development (adjusted OR¼ 6.4, 95%
confidence interval (CI)¼ 1.9–22.3) and stage 2 AKI
(adjusted OR¼ 20.0, 95% CI¼ 4.1–97.5). When CysC was
expressed as percent change from preoperative value, the
highest tertile of percent CysC change was independently
associated with development of stage 1 and 2 AKI (Table 3).
Adding CysC concentration to the model to predict AKI
including clinical variables alone resulted in an increase in
AUC of 7% for predicting stage 1 AKI (Po0.01 for increase
in AUC) and anB5% increase in AUC for predicting stage 2
AKI (P¼ 0.09).
First postoperative percent SCr change was also
independently associated with the development of stage 1
AKI, but not of stage 2 AKI (Table 3). When percent SCr
change was added to the clinical variable predictive model,
AUC increased by B5% for predicting future stage 1 AKI
(Po0.01), but by only B2% for predicting stage 2 AKI
(P¼ 0.2). When time after surgery (hours) of first post-
operative blood sample was controlled for in all analyses, ORs
were nearly identical except confidence intervals (CIs) were
wider.
Predicting length of stay and duration of mechanical
ventilation
The associations between first postoperative CysC value (mg/
dl), percent CysC change from baseline and percent
SCr change from baseline and length of hospital or intensive
care unit stay and duration of mechanical ventilation, were
evaluated. In all, 288 (72%) of children were still mecha-
nically ventilated at the time of first postoperative CysC
and SCr measurement. Figure 2 displays that there was a
statistically significant association between increasing
first postoperative CysC value and longer duration of
mechanical ventilation, in univariate analyses (Po0.001,
Jonckheere-Terpstra test).
Table 2 | Comparison of preoperative CysC and preoperative eGFR as predictors of postoperative stage 1 and stage 2 AKI
Stage 1 AKI (#events=121) Stage 2 AKI (#events=47)
Association of preoperative renal function with AKIa
Unadjusted OR (95% CI) Adjusted OR (95% CI)b Unadjusted OR (95% CI) Adjusted OR (95% CI)b
Pre-operative CysC (mg/l) 5.2 (2.2, 12.2) 1.4 (0.5, 4.4) 5.5 (1.9, 16.2) 2.1 (0.5, 9.0)
Pre-operative eGFR (ml/min per 1.73m2) 1.2 (0.5, 2.6) 8.4 (2.7, 25.9) 2.9 (0.9, 9.0) 34.9 (7, 174.3)
Pre-operative eGFR percentile 1.3 (1.1, 1.7) 1.5 (1.2, 2.0) 1.6 (1.1, 2.3) 1.9 (1.2, 3.0)
Area under receiver operating characteristic curvea
Unadjusted AUC (95% CI) Adjusted AUC (95% CI)b Unadjusted AUC (95% CI) Adjusted AUC (95% C)b
Clinical variables onlyc NA 0.73 (0.67, 0.80) NA 0.79 (0.70, 0.87)
Pre-operative CysC (mg/l) 0.63 (0.57, 0.70) 0.74 (0.68, 0.80) 0.62 (0.53, 0.72) 0.79 (0.70, 0.87)
Pre-operative eGFR (ml/min per 1.73m2) 0.51 (0.44, 0.58) 0.77 (0.71, 0.82)d 0.59 (0.50, 0.68) 0.84 (0.77, 0.92)d
Pre-operative eGFR percentile 0.66 (0.59, 0.72) 0.76 (0.70, 0.82)d 0.68 (0.60, 0.77) 0.82 (0.74, 0.90)d
Abbreviations: AKI, acute kidney injury; AUC, area under the curve; CI, confidence interval; CysC, cystatin C; eGFR, estimated GFR; GFR, glomerular filtration rate; NA, not
applicable; OR, odds ratio.
aNote: preoperative CysC, eGFR, and eGFR percentile were transformed to their logarithm for inclusion in logistic regression analyses.
bAdjusted for age, gender, Risk Adjustment in Congenital Heart Surgery (RACHS)-1 score, cardiopulmonary bypass time, and study site.
cThis model includes only clinical variables (age, gender, RACHS-1 score, cardiopulmonary bypass time, and study site), to determine how accurately AKI may be predicted
without the use of biomarkers.
dAdding preoperative eGFR to the clinical model led to a significant increase in AUC (Po0.05), compared with clinical variables alone.
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In multiple linear regression analyses, adjusting for clinical
factors, only first postoperative percent CysC change from
baseline (P¼ 0.04) and first postoperative CysC value
(Po0.001), but not percent SCr change from baseline, were
independently associated with longer duration of mechanical
ventilation. Only first postoperative CysC value was inde-
pendently associated with longer length of hospital stay
(P¼ 0.04). First postoperative percent SCr change from
baseline (P¼ 0.02) and first postoperative CysC value
(P¼ 0.002), but not percent CysC change from baseline,
were associated with longer length of intensive care unit stay.
DISCUSSION
In this multicenter study of children undergoing cardiac
surgery, higher CysC concentrations obtained within the first
6 h of surgery strongly predicted stage 2 (more severe) AKI
development in the subsequent days, as well as longer
duration of mechanical ventilation and longer length of stay.
We found that preoperative CysC did not predict the
development of postoperative AKI. However, higher pre-
operative eGFR and percent SCr change in the first 6 h after
surgery predicted the development of postoperative stage 1
(or mild) AKI. This is the first study to directly compare two
markers of GFR, SCr and CysC, for early prediction of AKI in
children.
Preoperative CysC concentrations were not associated
with development of postoperative AKI, when adjusted for
other clinical factors, such as cardiopulmonary bypass time,
demographics, and surgical severity score. Interestingly,
we found that higher and not lower preoperative eGFR was
Table 3 | Postoperative stage 1 and 2 AKI prediction with CysC and SCr, in subjects with no immediate postoperative AKI event
Stage 1 AKIa (#events=79) Severe AKIa (#events=30)
Association of postoperative renal function with AKI
% With stage 1
AKIb
Unadjusted
OR (95% CI)
Adjusted
OR (95% CI)c
% With stage 2
AKIb
Unadjusted
OR (95% CI)
Adjusted
OR (95% CI)c
CysC valued
1st Quintile 21 1 (Referent) 1 (Referent) 4 1 (Referent) 1 (Referent)
2nd Quintile 13 0.5 (0.2, 1.6) 0.5 (0.2, 1.8) 6 1.5 (0.2, 9.4) 1.7 (0.2, 13.8)
3rd Quintile 28 1.4 (0.6, 3.5) 1.4 (0.4, 4.5) 6 1.5 (0.2, 9.4) 2.5 (0.2, 27.3)
4th Quintile 37 2.2 (0.9, 5.4) 2.0 (0.6, 6.8) 19 5.8 (1.2, 28.0) 3.5 (0.4, 33.4)
5th Quintile 59 5.4 (2.2, 13.2) 6.0 (1.5, 23.3) 23 7.3 (1.6, 34.6) 17.2 (1.6, 189.3)
% CysC changee
1st Tertile 24 1 (Referent) 1 (Referent) 9 1 (Referent) 1 (Referent)
2nd Tertile 24 1.0 (0.5, 2.2) 0.9 (0.4, 2.3) 9 1.0 (0.4, 2.7) 1.6 (0.4, 6.4)
3rd Tertile 47 2.9 (1.5, 5.8) 4.4 (1.8, 10.8) 16 1.8 (0.7, 4.6) 5.7 (1.4, 24.0)
% SCr changef
1st Tertile 11 1 (Referent) 1 (Referent) 7 1 (Referent) 1 (Referent)
2nd Tertile 25 2.7 (0.8, 9.7) 3.1 (0.8, 11.9) 7 1.0 (0.2, 4.7) 0.6 (0.1, 3.2)
3rd Tertile 49 8.2 (2.3, 28.9) 9.6 (2.4, 39.0) 20 3.3 (0.7, 15.1) 1.4 (0.3, 8.4)
Area under the receiver operating characteristic curve
Unadjusted AUC (95% CI) Adjusted AUC (95% CI)c Unadjusted AUC (95% CI) Adjusted AUC (95% CI)c
Clinical variables onlyg NA 0.77 (0.70, 0.83) NA 0.85 (0.76, 0.93)
CysC value 0.70 (0.63, 0.78) 0.81 (0.75, 0.88) 0.70 (0.60, 0.81) 0.89 (0.81, 0.97)
% CysC change 0.62 (0.54, 0.70) 0.80 (0.73, 0.86) 0.59 (0.48, 0.70) 0.88 (0.80, 0.96)
% SCr change 0.71 (0.63, 0.78) 0.83 (0.77, 0.90) 0.64 (0.53, 0.75) 0.84 (0.76, 0.93)
Abbreviations: AKI, acute kidney injury; CI, confidence interval; CysC, cystatin C; OR, odds ratio; SCr, serum creatinine.
aTotal subjects in analysis differ between the stage 1 and 2 AKI events, because only subjects without the event (stage 1 AKI on the left side of the Table or stage 2 AKI on the
right side of the Table) immediately postoperatively were included. There were 241 patients in the stage 1 AKI prediction analyses and 267 patients in the stage 2 AKI
prediction analyses.
b% Patients who developed AKI (stage 1 AKI on the left side of the Table and stage 2 AKI on the right side of the Table) within each quintile or tertile (these should not add up
to 100%).
cAdjusted for age, gender, Risk Adjustment in Congenital Heart Surgery (RACHS)-1 score, preoperative estimated glomerular filtration rate, cardiopulmonary bypass time, and
study site.
dQuintile CysC concentrations (mg/dl) for stage 1 AKI event analyses (from 1st to 5th quintiles) were 0.31–0.53, 0.53–0.64, 0.64–0.77, 0.77–1.01, 1.01–2.91; for the stage 2 AKI
analyses, 1st to 5th quintiles were 0.31–0.53, 0.53–0.65, 0.65–0.77, 0.77–1.00, 1.00–2.91. The number of patients per quintile for the stage 1 AKI analysis: Q1 n=47, Q2 n=48, Q3
n=47, Q4 n=46, Q5 n=49 and for the stage 2 AKI analysis: Q1 n=52, Q2 n=52, Q3 n=52, Q4 n=53, Q5 n=53.
eTertiles of % CysC rise for the stage 1 AKI event analyses were 50 to 15%, 15 to 5%, 5–143%; for the stage 2 AKI analyses, 1st to 3rd tertiles were 50 to 15%, 15 to
4%, 4–143%. The number of patients per tertile for the stage 1 AKI analysis: n=79 and for the stage 2 AKI analysis n=87 except for the 3rd tertile n=88.
fTertiles of SCr % change for stage 1 AKI analyses: 33 to 0%, 0–25%, 25–50%; for stage 2 AKI analyses: 33 to 0%, 0–33%, 33–85%. The number of patients per tertile in the
stage 1 AKI analysis; T1 n=28, T2 n=118, T3 n=95 and for stage 2 AKI analysis; T1 n=28, T2 n=143, T3 n=96.
gThis model includes only clinical variables (age, gender, RACHS-1 score, cardiopulmonary bypass time, and study site), to determine how accurately AKI may be predicted
without the use of biomarkers.
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associated with the development of AKI, even when we
meticulously adjusted for age-associated differences in GFR
by deriving GFR percentile values and adjusting for age in
multivariate analyses. These two findings appear to refute our
underlying hypothesis that preoperative CKD is a risk factor
for AKI, as has been suggested by adult studies11 and in one
study of AKI in children treated with aminoglycosides.17
A potential explanation is that children who are malnour-
ished with lower muscle mass and consequently lower SCr
concentrations (resulting in higher eGFR), are at increased
risk for AKI development. This highlights the limitations of
using SCr for GFR estimations. However, it is also possible
that because few subjects had preoperative CKD, we may not
have been able to detect a CKD–AKI association. Another
possible confounding factor is that the Schwartz formula,
which was derived from children greater than 2 years of age
with established CKD,18 overestimates GFR, particularly in
infants or children with fairly preserved renal function.
This is supported by the fact that the median preoperative
eGFR percentile value for children under 2 years old was the
81st percentile, compared with the 41st percentile in older
children (shown in Figure 1, for children less than 2 years
old), suggesting that eGFR is overestimated in younger
children. We did not estimate GFR using published CysC
equations, as none of them have been validated in infants.
These results provide a serendipitous indicator that future
studies should attempt to derive equations from SCr and
CysC specific to younger children, as well as to children with
GFR approaching the normal range, which may help better
identify mild CKD as a risk factor for postoperative AKI.
Finally, it is possible that the use of a SCr-based AKI
definition is an imperfect, yet only available, reference
standard, which is currently a challenge for all AKI studies.
From our previous work, we discovered that almost all
postoperative cardiac surgery-associated AKI occurs within
the first 3 days after surgery.3 Therefore, AKI therapeutic
trials in this population will need to provide an intervention
as early as possible during or after surgery. We found that
postoperative serum CysC concentrations in the 5th quintile
(41.01 mg/dl), obtained very early after surgery, indepen-
dently predicted development of stage 2 AKI. The cut-point
of 1.16 mg/dl from a recent single-centre study was strongly
associated with AKI severity.16 Thus, early postoperative
CysC may be helpful for future clinical trials aimed at
reducing the incidence of SCr doubling and dialysis need or
other clinical outcomes such as duration of ventilation.
We also found that clinical variables that are easily deter-
minable immediately after surgery provided fairly good
prediction of postoperative AKI development. It is likely that
using a combination of clinical and early postoperative
biomarker data will provide the best method for determining
eligibility into future AKI clinical trials in children under-
going cardiac surgery, to optimize sensitivity and specificity.
Although we have demonstrated that CysC may have a role
in early stage 2 AKI identification for trials, it is still unclear
to what extent CysC should be used in clinical care. CysC
currently costs significantly more to measure than SCr does,
though cost will hopefully become less of a hindrance in time.
Second, as we currently do not have specific treatments for AKI
in children, whether or not incorporating CysC into clinical
care will improve outcome will remain unknown until trials
are performed. Therefore, we propose that future AKI clinical
trials should incorporate measurement of CysC and cost ana-
lyses as outcomes. Trials examining currently available mea-
sures of managing AKI (such as early dialysis initiation or early
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Figure 2 |Association of postoperative serum creatinine (SCr)
and cystatin C (CysC) with duration of ventilation. Displays
mean duration of mechanical ventilation (days) for the
(a) quintiles of first postoperative CysC concentrations, (b) tertiles
of first postoperative percent CystC change and (c) tertiles of first
postoperative percent SCr change from baseline. Standard errors
were extremely low (ranging from 0.01 to 0.04, and are not
displayed). Univariate P-values for test of linear trend are
displayed.
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goal-directed fluid management) should examine if knowledge
of early postoperative CysC concentrations would lead to
changes in outcomes such as duration of mechanical ventila-
tion or management of fluid balance and oxygenation.
The results of our study justify thorough evaluations of
incorporating CysC into clinical care of this population.
Our study had several unique strengths. This is the first
multicenter study of AKI and new AKI biomarkers in
children, and to our knowledge the first study to examine
specifically the role of preoperative renal function for AKI
prediction in children. Because the timing of the most likely
renal injurious event was known (cardiopulmonary bypass
surgery), we were able to identify a clinically reproducible
time point on which to evaluate CysC for early AKI
prediction. Our use of eGFR percentiles for expressing
preoperative renal function is novel and likely more valid for
expressing renal function in younger children who are known
to have an expected age- and development-associated lower
raw eGFR value compared with older children. Another
strength was our careful exclusion of subjects who already
had clear evidence of AKI immediately postoperatively, when
evaluating the ability of CysC to truly predict AKI earlier
than SCr can. We evaluated doubling of SCr or need for
dialysis (stage 2 AKI) as one of our primary outcomes. Thus,
our findings will be useful for future clinical trials for AKI,
which are likely to use a similar clinically meaningful
outcome.
A limitation of this study was the somewhat restricted
sample size, which did not allow us to adequately evaluate for
effect modification and led to poor precision around some
estimates, with wide CIs. Although the low prevalence of
significant preoperative CKD was a limitation in being able to
assess the CKD–AKI relation, our finding that few children
having complex heart surgery have baseline CKD was
important to demonstrate for future studies and under-
standing this population. Our study was limited to children
undergoing cardiac surgery; therefore, the findings may not
be immediately generalizable to all other hospitalized
children and similarly rigorous studies in other non-cardiac
pediatric populations are warranted.
In conclusion, the use of clinical risk factors may have an
important role in predicting postoperative AKI in children
who have had cardiac surgery. Early postoperative CysC is a
useful marker to predict development of AKI but preopera-
tive CysC does not contribute significantly. More research is
required to better understand how to estimate preoperative
renal function in young children and in children with GFR in
the normal to mildly low range.
MATERIALS AND METHODS
Study design and study population
The Translational Research Investigating Biomarker Endpoints in
AKI (TRIBE-AKI) study was a prospective USA–Canada, multi-
center cohort study of patients undergoing cardiac surgery,
with the objective to validate biomarkers of AKI. Three pediatric
centers were included: Cincinnati Children’s Hospital Medical
Center (Cincinnati), Yale Children’s Hospital (Yale), and Montreal
Children’s Hospital (Montreal). All children undergoing cardio-
pulmonary bypass surgery for congenital cardiac surgery repairs
were eligible. Patients with end stage renal disease or overt
preoperative AKI (known SCr increase of X44.2 mmol/l from
baseline before surgery) were excluded. For this analysis, we
excluded subjects who were less than 1-month-old (due to
challenges and controversies in defining AKI in the neonatal
population19). We also excluded patients who did not have
preoperative SCr, CysC, and height as well as postoperative SCr
and CysC available. All centers obtained institutional internal review
or research ethics board approval before study initiation and
parental informed consent was obtained from all subjects.
Study procedure
Procedure aspects pertinent to this study are reported. Subjects
were recruited preoperatively within 1 month of surgery. Blood
samples were obtained during routine phlebotomy at the time of
preoperative evaluation or on anesthesia induction, for SCr
and CysC measurement. On admission to the intensive care unit,
additional blood was drawn for CysC measurement within 6 h of
surgery and was concurrent with the first planned routine blood
testing. SCr was measured routinely by the treating team,
from shortly after surgery (at the same time as the first postoperative
CysC measurement) and every morning thereafter during intensive
care unit and hospital stay. Blood for CysC measurement was
centrifuged and the plasma aliquoted for storage at 80 1C
until shipped for measurement. Each individual subject had
pre- and postoperative SCr measured using the same SCr assay
at the same laboratory. CysC was measured using a nephelo-
meter (Siemens BN-II, Siemens, AG; www.Siemens.com) at the
Cincinnati Children’s Hospital Biomarker Laboratory (coefficient of
variation¼ 1.1%). Individuals performing the SCr and CysC assays
were blinded to the clinical data.
Clinical data collection
The following clinical variables were collected: age, gender, study
site, cardiopulmonary bypass time, and the Risk Adjustment in
Congenital Heart Surgery (RACHS-1) score.20 RACHS-1 contains
six categories designed to differentiate surgical risk for mortality on
the basis of procedure. Height was recorded to calculate preopera-
tive eGFR.
Pre-operative renal function assessment
One of our objectives was to evaluate the ability of preoperative
renal function to predict postoperative AKI. Pre-operative renal
function was assessed by preoperative CysC and SCr concen-
trations. Pre-operative CysC was expressed as actual concentration
values (mg/dl). Pre-operative SCr was expressed as estimated GFR
(eGFR, by the Schwartz formula 36.5 height in cm/SCr in mmol/l),18
because of the dependence of SCr concentrations on muscle mass.
We noted a methodological challenge of eGFR interpretation in
younger children. Children less than 2 years old have a physio-
logically lower GFR than older children,21 making it difficult to use
raw eGFR as a risk factor of AKI when studying children aged 1
month to 18 years old. One previous study of children with normal
renal function from ages 0.1 to 19 years old reported measurement of
nuclear medicine scan GFR in 651 individuals.22 We generated
percentile value GFR norms according to age, using the data provided
by the corresponding author. We plotted our subjects’ preoperative
eGFR percentiles using these normative values (shown in Figure 1).
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To understand how the utilization of raw versus percentile
preoperative eGFR values affected our results, we analyzed both
methods of preoperative eGFR expression (eGFR in ml/min per
1.73 m2 and eGFR percentile value).
First postoperative SCr and CysC evaluation
Our goal was to provide a comparison of the ability of first
postoperative SCr versus first postoperative CysC concentrations to
predict development of the AKI outcomes, to elucidate to what
extent utilizing CysC would lead to improved AKI prediction over
the current standard biomarker, SCr. We expressed the first
postoperative SCr value as a percentage change from preoperative
concentrations (first postoperative SCr/preoperative SCr 100).
Because there was little prior research on use and interpretation of
CysC in the intensive care unit, we expressed the first postoperative
CysC concentrations in 2 ways: (1) as raw first postoperative CysC
concentration (mg/dl) and (2) as a percentage change from
preoperative concentrations, similar to how SCr was expressed
(first postoperative CysC/preoperative CysC 100). We also eval-
uated the presence of first postoperative CysC value of o versus
X1.16 mg/dl, based on a significant postoperative CysC cutoff
found to be predictive of postoperative cardiac surgery-associated
AKI, in a previously published single-centre pediatric study.16
Definition of AKI
AKI was defined according to the Acute Kidney Injury Network
(AKIN) staging.23 We evaluated two primary postoperative AKI
outcomes: (1) ‘mild AKI’ or stage 1 AKI according to the AKIN
staging (X50% SCr rise from baseline or a 26.5 mmol/l SCr rise from
baseline or need for dialysis) and (2) ‘severe AKI’ or stage 2 AKI
according to the AKIN staging (doubling of SCr from baseline or
need for dialysis).
Other outcomes
We evaluated length of intensive care unit and hospital stay and
duration (days) of mechanical ventilation as secondary outcomes.
There were only four deaths, therefore we could not evaluate
mortality as an outcome.
Statistical analysis
Continuous variables were expressed as mean±standard deviation
and categorical variables as proportions (n, %). To calculate
preoperative eGFR percentiles a quantile regression model using
intercept and log-transformed age, in childreno and X2 years old,
was fitted using data from the normal renal function pediatric
patient study by Piepsz et al.22 The proc quantreg procedure
of the SAS 9.2 statistical software (Cary, NC) was used for this
analysis.
To evaluate the association between preoperative renal function
(preoperative CysC, eGFR, and eGFR percentile) and postoperative
stage 1 AKI or stage 2 AKI, multiple logistic regression was used,
controlling for age (o or X2 years old), gender, RACHS-1 score (1
or 2 versus 3 versus 4), study site (as a fixed effect), and
cardiopulmonary bypass time (p60, 61–90, 91–120, 121–180, or
X181 min). For these analyses, preoperative CysC, eGFR, and eGFR
percentile were expressed in the logarithmic scale to allow for similar
scaling between all three measures and to account for skewed
distribution. For pre-op eGFR percentile, we added 1 to all values
before logarithmic transformation as some percentile values were at
or near zero.
To evaluate the association between first postoperative percent
SCr change from baseline, percent CysC change from baseline or
first postoperative CysC value and development of stage 1 or 2 AKI,
we used multiple logistic regression, controlling for age (o or X2
years old), gender, RACHS-1 score (1 or 2 versus 3 versus 4), study
site (as a fixed effect), cardiopulmonary bypass time (p60, 61–90,
91–120, 121–180, or X181 min), as well as preoperative eGFR
percentile. We also evaluated whether the time (hours) of first
postoperative blood sampling affected results. For these analyses, we
expressed first postoperative percent SCr change and percent CysC
change from baseline into tertile categories and first postoperative
CysC values into quintile categories to adjust for non-normal
distribution of these values and also to enhance interpretation of the
derived ORs. Of note, we only included subjects in these analyses
who did not already have the AKI event on the first postoperative
blood sampling to avoid overestimating the predictive association of
CysC and already-diagnosable AKI. AUC for first postoperative
percent SCr and CysC change from baseline and for first
postoperative CysC value to predict stage 1 or 2 AKI was also
calculated. All AUC’s and OR’s were expressed as point estimates
and associated 95% CI. Differences in calculated AUC’s were tested
for significance using the test developed by DeLong et al.24
To evaluate the association between first postoperative SCr and
CysC to predict length of stay and duration of mechanical
ventilation, multiple linear regression was used, controlling for age
(o or X2 years old), gender, RACHS-1 score (1 or 2 versus 3 versus
4), study site, cardiopulmonary bypass time (p60, 61–90, 91–120,
121–180, or X181 min), preoperative eGFR percentile, and post-
operative time (hours) of first postoperative blood sampling. Because
of non-normal distribution of length of stay and of duration of
mechanical ventilation, we log-transformed these variables for
inclusion in regression analyses. Statistical software R version 2.10.1
and SAS 9.2 statistical software were used to perform all analyses.
DISCLOSURE
PD is a co-inventor on patents pertaining to neutrophil gelatinase-
associated lipocalin for the diagnosis of renal failure, and is a
consultant to Abbott Diagnostics and Biosite. CRP is a co-inventor on
patents pertaining to IL-18 for AKI and consultant to Abbott
Diagnostics.
ACKNOWLEDGMENTS
The study was supported by the NIH grant to CRP (RO1-HL085757).
MZ received research support from the Kidney Research Core
Education and National Training Program, the Montreal Children’s
Hospital Research Institute and the Fondation de Recherche en Sante
du Quebec. AXG was supported by a Clinician Scientist Award
from the Canadian Institutes of Health Research. We thank the study
site research co-ordinators who meticulously performed the study
procedures and data entry and the hospital staff for obtaining
preoperative blood specimens. We sincerely thank A Piepsz (Brussels,
Belgium) for sharing her data on nuclear medicine technology-
measured GFR in children with normal kidney
function, which we used to generate our GFR percentile values.
REFERENCES
1. D’Onofrio A, Cruz D, Bolgan I et al. RIFLE criteria for cardiac
surgery-associated acute kidney injury: risk factors and outcomes.
Congest Heart Fail 2010; 16(Suppl 1): S32–S36.
2. Li SY, Chen JY, Yang WC et al. Acute kidney injury network
classification predicts in-hospital and long-term mortality in
patients undergoing elective coronary artery bypass grafting surgery.
Eur J Cardiothorac Surg 2011; 39: 323–328.
Kidney International (2011) 80, 655–662 661
M Zappitelli et al.: CysC for early AKI diagnosis o r ig ina l a r t i c l e
3. Zappitelli M, Bernier PL, Saczkowski RS et al. A small postoperative rise in
serum creatinine predicts acute kidney injury in children undergoing
cardiac surgery. Kidney Int 2009; 76: 885–892.
4. Coca SG, Parikh CR. Urinary biomarkers for acute kidney injury:
perspectives on translation. Clin J Am Soc Nephrol 2008; 3: 481–490.
5. Haase M, Bellomo R, Devarajan P et al. Accuracy of neutrophil gelatinase-
associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney
injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 54:
1012–1024.
6. Ichimura T, Hung CC, Yang SA et al. Kidney injury molecule-1: a tissue and
urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol
Renal Physiol 2004; 286: F552–F563.
7. Mishra J, Ma Q, Prada A et al. Identification of neutrophil gelatinase-
associated lipocalin as a novel early urinary biomarker for ischemic renal
injury. J Am Soc Nephrol 2003; 14: 2534–2543.
8. American Society of Nephrology. American Society of Nephrology Renal
Research Report. J Am Soc Nephrol 2005; 16: 1886–1903.
9. Pakfetrat M, Nikoo MH, Malekmakan L et al. Comparison of risk factors for
contrast-induced acute kidney injury between patients with and without
diabetes. Hemodial Int 2010; 4: 387–392.
10. Skott M, Norregaard R, Sorensen HB et al. Pre-existing renal failure
worsens the outcome after intestinal ischaemia and reperfusion in rats.
Nephrol Dial Transplant 2010; 11: 3509–3517.
11. Singh P, Rifkin DE, Blantz RC. Chronic kidney disease: an inherent
risk factor for acute kidney injury? Clin J Am Soc Nephrol 2010; 9:
1690–1695.
12. Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill
patients: a multinational, multicenter study. JAMA 2005; 294: 813–818.
13. Zappitelli M, Parvex P, Joseph L et al. Derivation and validation of cystatin
C-based prediction equations for GFR in children. Am J Kidney Dis 2006;
48: 221–230.
14. Schwartz GJ, Work DF. Measurement and estimation of GFR in children
and adolescents. Clin J Am Soc Nephrol 2009; 4: 1832–1843.
15. Bagshaw SM, Bellomo R. Cystatin C in acute kidney injury. Curr Opin Crit
Care 2010; (e-pub ahead of print).
16. Krawczeski CD, Vandevoorde RG, Kathman T et al. Serum cystatin C is an
early predictive biomarker of acute kidney injury after pediatric
cardiopulmonary bypass. Clin J Am Soc Nephrol 2010; 5: 1552–1557.
17. Zappitelli M, Moffett BS, Hyder A et al. Acute kidney injury in non-critically
ill children treated with aminoglycoside antibiotics in a tertiary healthcare
centre: a retrospective cohort study. Nephrol Dial Transplant 2011; 1:
144–150.
18. Schwartz GJ, Munoz A, Schneider MF et al. New equations to estimate
GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629–637.
19. Askenazi DJ, Griffin R, McGwin G et al. Acute kidney injury is
independently associated with mortality in very low birthweight
infants: a matched case-control analysis. Pediatr Nephrol 2009; 24:
991–997.
20. Jenkins KJ, Gauvreau K, Newburger JW et al. Consensus-based method
for risk adjustment for surgery for congenital heart disease. J Thorac
Cardiovasc Surg 2002; 123: 110–118.
21. Atiyeh BA, Dabbagh SS, Gruskin AB. Evaluation of renal function during
childhood. Pediatr Rev 1996; 17: 175–180.
22. Piepsz A, Tondeur M, Ham H. Revisiting normal (51)Cr-
ethylenediaminetetraacetic acid clearance values in children. Eur J Nucl
Med Mol Imaging 2006; 33: 1477–1482.
23. Mehta RL, Kellum JA, Shah SV et al. Acute Kidney Injury Network: report
of an initiative to improve outcomes in acute kidney injury. Crit Care
2007; 11: R31.
24. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under
two or more correlated receiver operating characteristic curves: a
nonparametric approach. Biometrics 1988; 44: 837–845.
662 Kidney International (2011) 80, 655–662
or ig ina l a r t i c l e M Zappitelli et al.: CysC for early AKI diagnosis
